Entry Point Capital, LLC Haemonetics Corp Transaction History

Entry Point Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$56.04 - $74.77 $335,175 - $447,199	-5,981 Reduced 62.72%	3,555 $265,000
Q1 2025 May 14, 2025	BUY	$59.34 - $80.05 $396,509 - $534,894	6,682 Added 234.13%	9,536 $606,000
Q4 2024 Feb 11, 2025	SELL	$71.16 - $93.38 $280,583 - $368,197	-3,943 Reduced 58.01%	2,854 $222,000
Q3 2024 Nov 13, 2024	BUY	$72.45 - $91.58 $492,442 - $622,469	6,797 New	6,797 $546,000
Q1 2024 May 14, 2024	BUY	$71.24 - $85.35 $71,453 - $85,606	1,003 New	1,003 $85.6 Million

340

50M

666K

395K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.77B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Entry Point Capital, LLC with notifications on news.